-
Product Insights
Peabody – Higgs Yard Mixed-Use Community – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our Peabody - Higgs Yard Mixed-Use Community - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Peabody – Higgs Industrial Estate Mixed-Use Development – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our Peabody - Higgs Industrial Estate Mixed-Use Development - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Insights
Avery Dennison Corporation – Digital Transformation Strategies
Avery Dennison has been focusing on AI-led innovation as a part of its digital transformation strategies. The annual ICT spending of Avery Dennison was estimated at $371.2 million in 2022. A major share of this spending is earmarked for acquiring software, hardware, and consulting from vendors. Avery Dennison is a provider of labeling and packaging materials and solutions It produces pressure sensitive materials, tags, labels, tickets, fasteners, tickets, radio frequency identification (RFID) inlays, imprinting equipment, and related services. The Avery...
-
Sector Analysis
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Injectables and their packaging requirements are very important to marketed treatments given the volume of vaccines required to tackle the COVID-19 pandemic and the rising number of biologics in development pipelines and on the market. Most injectable drugs in the development pipeline are biologics, which will become increasingly approved and more established in the treatment landscape in the future. The top contract packaging organizations (CPOs) for injectables by the number of contracts are standalone packagers along with large CMOs which...